Identification, mapping, and engagement of KOLs or key opinion leaders in healthcare play a significant role in drug trials for pharmaceutical and biotech corporations, making us the most preferred partner in the industry.
KOLs or key opinion leaders in healthcare are influencers and drivers of the latest therapy, drugs/devices based on sound research, their involvement in the domains of research, and their networking in distinct markets.
At SG Analytics (SGA), we assist our clients with KOL mapping in healthcare to identify the key opinion leaders who can navigate our industry clients to build the right connections, relationships, and more. This can lead to the creation of a comprehensive disease ecosystem wherein the client’s drug or device must compete and thrive.
SGA has a panel of KOLs spread across >30 sub-specialties and >15 hierarchies, including CXO levels to senior managers and distributors. Our panelists will guide you through a client’s product lifecycle and clinical trials, along with sharing the market sentiments, perceptions, and expectations. Our multilingual analysts can help you connect with these influencers in non-English-speaking markets as well as English-speaking markets.
Why SGA
Industry Leader
SGA thrives by its brand promise Life is Possible, and is recognized as the most trusted healthcare market research company.
12+ Languages
Language capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English experts (US/UK).
Data-Driven Insights
With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we deliver high-quality, efficient outputs.
End-To-End Solutioning
SGA has an in-house KOL (key opinion leader) capability of more than 700, located across major as well as new markets, which help in presenting credible competitive information.
White Papers
Market Entry in 2023: Why Must You Also Look at Markets Other Than the US and Japan?
Due to dollar fluctuations and the likelihood of market recession, investors and manufacturers of medical devices and pharma are exploring new opportunities...
White Papers
The Blue Ocean Strategy in the Pharmaceutical Industry: What Is the Blue Ocean Strategy About?
Blue ocean refers to a new market that presents low competition, is less crowded, and is open to accommodate new innovations and marketing opportunities....
White Papers
What Happens When You Invest in Healthcare Consulting and Analytics?
Healthcare providers who are struggling with high-volume complex data are feeling the need for assistance with data convergence and management. With...
We strongly believe in women power. Our research team consists of more females than males i.e., 55 % females, and consists of PhDs, M Pharms, D Pharms, Postgraduate in finance, Biotech postgraduates, and MBAs.
